We are live on ! Find out more
ADGM

Adagio Medical Holdings

15 hedge funds and large institutions have $22.6M invested in Adagio Medical Holdings in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

52% more capital invested

Capital invested by funds: $14.9M → $22.6M (+$7.69M)

25% more funds holding

Funds holding: 1215 (+3)

1.39% less ownership

Funds ownership: 77.05%75.67% (-1.4%)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

ADGM Hedge Fund Activity: Q3 2025 in Review

15 institutional investors reported a position in Adagio Medical Holdings (ADGM) for Q3 2025, worth a combined $22.6M — up 52% from $14.9M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ADGM positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $368K. The largest seller was Shaolin Capital Management, cutting an estimated $677K.

  • 15 institutional investors held Adagio Medical Holdings (ADGM) as of Q3 2025, up from 12 in Q2 2025.
  • Funds reported $22.6M of Adagio Medical Holdings stock for Q3 2025, up 52% quarter-over-quarter.
  • 4 funds opened new Adagio Medical Holdings positions in Q3 2025 and 1 closed out, a net change of +3 holders.
  • The largest Adagio Medical Holdings buyer in Q3 2025 was Adage Capital Partners, an estimated $368K added.
  • The largest Adagio Medical Holdings seller in Q3 2025 was Shaolin Capital Management, an estimated $677K sold.

Based on aggregated 13F filings for Q3 2025.